Pediatric Orthopedic Implants Global Market Report 2024

The pediatric orthopedic implants market size has grown rapidly in recent years. It will grow from $1.71 billion in 2023 to $1.89 billion in 2024 at a compound annual growth rate (CAGR) of 10.6%. Historical growth in the pediatric orthopedic implant sector was propelled by advancements in surgical techniques specific to pediatric orthopedics. Additionally, the rise in pediatric orthopedic conditions, a surge in sports-related injuries among children, increased educational efforts, and the development of specialized orthopedic subfields for children significantly contributed to this growth.

The pediatric orthopedic implants market size is expected to see strong growth in the next few years. It will grow to $2.71 billion in 2028 at a compound annual growth rate (CAGR) of 9.4%. Anticipated growth in the pediatric orthopedic implant sector is expected due to a shift toward personalized and tailored implant solutions. This forecast also accounts for heightened attention on minimally invasive procedures, a rising incidence of musculoskeletal disorders in pediatric patients, and an expansion in cases related to pediatric trauma. Notable trends in this period are projected to include collaborative efforts in research and development, innovative designs for implants driven by technological advancements, improvements in imaging technologies, developments in implant materials, and the integration of telehealth in pediatric orthopedic care.

The anticipated rise in the pediatric population is poised to drive the growth of the pediatric orthopedic implants market. Defined as individuals in the early stages of development who have not yet attained maturity, children stand to benefit from pediatric orthopedic implants, which offer advantages such as pain reduction, swelling alleviation, and assistance in limb mobility. For example, a report from the UK's Office for National Statistics in August 2022 revealed a 1.8% increase in live births in England and Wales, reaching 624,828 in 2021 from 613,936 in 2020. This surge in child numbers contributes significantly to the expansion of the pediatric orthopedic implants market.

The escalating occurrence of sports injuries is expected to be a key driver for the growth of the pediatric orthopedic implants market. Sports injuries, encompassing physical harm sustained during athletic activities, necessitate the use of pediatric orthopedic implants for stabilizing fractures and repairing growth plate injuries in children. These implants provide structural support, facilitating the proper healing of bones and the restoration of normal function. As an illustration, data from the Australian Institute of Health and Welfare in June 2023 indicated that wheeled sports and various forms of football accounted for the highest number of injury-related hospitalizations in 2020 and 2021 in Australia. Cycling, for instance, reported approximately 9,800 cases, followed by soccer (5,100), roller sports (5,000), and rugby (5,000). Consequently, the rising incidence of sports injuries serves as a significant catalyst for the pediatric orthopedic implants market.

The pediatric orthopedic implants market is witnessing a notable trend characterized by a focus on product innovations. Leading companies in the market are actively engaged in the development of novel products to fortify their market positions. An exemplar of this trend is Orthofix Medical, a US-based medical company, which introduced a pediatric implant as part of the fit bone limb-lengthening system in September 2021. This system, available in diameters 9mm, 11mm, and 13mm, caters to patient demands and stands out as the sole intramedullary limb lengthening treatment approved by the U.S. Food and Drug Administration (FDA) for use in both children and adults. Notably, the fit bone system is now compatible with the OrthoNext digital platform, featuring a reverse planning method module for enhanced preoperative assessment accuracy.

Prominent companies in the pediatric orthopedic implants market are directing their efforts toward advanced solutions, including the integration of patented modular quick-clip technology. This proprietary technology aims to expedite the assembly or connection of modular components in diverse applications or devices, thereby enhancing surgical precision, reducing operative time, and optimizing patient outcomes. An illustrative instance is the November 2023 launch by OrthoPediatrics Corporation, a US-based medical devices company, of the Mitchell Ponseti Plus Bar (MP+). Part of their specialty bracing portfolio for children with clubfoot, this orthopedic device employs patented modular quick-clip technology and features elastomer bumpers on the heels, expanding the width range for a customized fit.

In July 2022, OrthoPediatrics Corporation, a U.S.-based medical devices company, completed the acquisition of Pega Medical for $33 million. Through this strategic acquisition, OrthoPediatrics aims to broaden its pediatric orthopedics portfolio, thereby extending support to a larger demographic of children affected by orthopedic disorders. Pega Medical, based in Canada, specializes in the creation and manufacturing of pediatric orthopedic implants, aligning with OrthoPediatrics' vision of expanding its product range for pediatric orthopedic solutions.

Major companies operating in the pediatric orthopedic implants market report are Medtronic Plc., Stryker Corporation, B. Braun SE, DePuy Synthes, Zimmer Biomet, Smithy & Nephew Plc., Arthrex Inc., NuVasive Inc., DJO Global, CONMED Corporation, Globus Medical, Orthofix Medical Inc., Wittenstein intens GmbH, Corin Group, OrthoPediatrics Corporation, SI-BONE Inc., FH Orthopedics, Baumer S.A., Acumed, Merete Medical GmbH, JRI Orthopaedics Limited, GPC Medical Ltd., Samay Surgical, Auxein Inc., Wishbone Medical Inc., Waldemar Link GmbH & Co. KG, Implantcast GmbH, Bioretec Ltd., Suhradam Ortho, Vast Ortho.

North America was the largest region in the pediatric orthopedic implants market in 2023. The regions covered in the pediatric orthopedic implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pediatric orthopedic implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

Diverse categories of pediatric orthopedic implants include hip, spine, knee, dental, craniomaxillofacial implants, among others. Hip implants, for instance, are prosthetic components used to replace or repair damaged hip joints. These implants cater to an array of applications, including birth defects, fractures, bone and joint infections, spinal irregularities, and more. These devices serve hospitals, pediatric clinics, and other medical facilities.

The pediatric orthopedic implants market research report is one of a series of new reports that provides pediatric orthopedic implants market statistics, including pediatric orthopedic implants industry global market size, regional shares, competitors with a pediatric orthopedic implants market share, detailed pediatric orthopedic implants market segments, market trends and opportunities, and any further data you may need to thrive in the pediatric orthopedic implants industry. This pediatric orthopedic implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pediatric orthopedic implants market consists of sales of spinal implants, joint implants, external fixation devices, intramedullary (IM) nails, plates, screws, and bone graft replacements. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.


The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).


The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.